MORRAB SURGERY
2 MORRAB ROAD, PENZANCECKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 4 | 4 | 100.0% | |
CKD 4 | 2008 | 82 | 90 | 91.1% | |
CKD 5 | 2009 | 24 | 24 | 100.0% | |
CKD 5 | 2010 | 41 | 46 | 89.1% | |
CKD 5 | 2011 | 43 | 48 | 89.6% | |
CKD 5 | 2012 | 35 | 41 | 85.4% | |
CKD 5 | 2013 | 40 | 44 | 90.9% | |
CKD003 | 2014 | 40 | 43 | 93.0% | |
CKD003 | 2015 | 34 | 37 | 91.9% | |
NM84 | 2016 | 31 | 44 | 70.5% | |
NM84 | 2018 | 35 | 59 | 59.3% | |
NM84 | 2019 | 37 | 63 | 58.7% | |
NM84 | 2020 | 32 | 53 | 60.4% | |
NM84 | 2022 | 17 | 29 | 58.6% |